Company · CIK 0001635077 · SIC 8071 — Services-Medical Laboratories · Nasdaq
Aclarion, Inc. · ACON
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 PForm 4 → | Aug 19, 8:30 am EDT | Amanda M WilliamsDirector | 5,857 | $2.73 | $15,990 | 25,857 | +29.3% | |
| Aug 14, 2026 PForm 4 → | Aug 18, 8:30 am EDT | Gregory A GouldCFO | 10,000 | $2.45 | $24,500 | 60,000 | +20.0% | |
| Aug 13, 2026 PForm 4 → | Aug 17, 8:30 am EDT | Ryan BondDirector | 21,122 | $2.37 | $50,059 | 76,122 | +38.4% | |
| Aug 13, 2026 PForm 4 → | Aug 17, 8:30 am EDT | William WesemannDirector | 2,150 | $2.34 | $5,031 | 23,713 | +9.97% | |
| Aug 13, 2026 PForm 4 → | Aug 17, 8:30 am EDT | David K NealDirector | 7,500 | $2.40 | $18,000 | 30,002 | +33.3% | |
| Aug 13, 2026 PForm 4 → | Aug 17, 8:30 am EDT | Brent NessChief Executive Officer, Director | 5,234 | $2.31 | $12,091 | 111,534 | +4.92% | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | Ryan BondChief Strategy Officer | 55,000 | — | — | 55,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | Amanda Mae SequiraDirector | 20,000 | — | — | 20,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | Scott BreidbartDirector | 20,000 | — | — | 25,664 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | Gregory A GouldChief Financial Officer | 50,000 | — | — | 50,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | Brent NessChief Executive Officer, Director | 100,000 | — | — | 106,300 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | William WesemannDirector | 20,000 | — | — | 21,563 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | Jeffrey John ThramannExecutive Chairman, Director | 100,000 | — | — | 100,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | David K NealDirector | 20,000 | — | — | 22,502 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:30 pm EDT | Stephen DeitschDirector | 20,000 | — | — | 20,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.